Omeprazole in GERD does not lead to anti-gastric autoantibody productionBergmanNews
Management strategies for gastro-oesophageal reflux disease (GERD) are often inconsistent with the proposition that it is a persistent or chronic disease. To determine the persistence of reflux symptoms and complications associated with GERD. Systematic searches of Medline and EMBASE. In longitudinal stud...
The authors point out that standard triple therapy with omeprazole, clarithromycin and amoxicillin (OCA) in the Spanish population achieved per protocol cure rates of only 66%, whilst levo-floxacin-based triple therapy (OLA), and sequential therapy with either clarithromycin (OACM) or levofloxacin ...
Omeprazole does not reduce GERD: new insightsJeffrey PetersNews